Skip to content

AustralianSuper Pty Ltd: EW position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of AustralianSuper Pty Ltd on EW, newest first. How the timeline and the estimate are built.

AustralianSuper Pty Ltd held 0 EW shares at 2025-09-30 per its 13F-HR/A filed 2025-11-12.

the latest 13F is the newest step

  1. period ended2025-09-30
    13F/A 0 shares
    Change vs previous 13F -559,115 shares

    13F-HR/A 0001694164-25-000015 filed by AustralianSuper Pty Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2025-06-30
    13F 559,115 shares
    Change vs previous 13F -984,313 shares

    0.22% of the 13F portfolio, value $43,728,384.

    13F-HR 0001694164-25-000007 filed by AustralianSuper Pty Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-03-31
    13F 1,543,428 shares
    Change vs previous 13F -1,125,415 shares

    0.63% of the 13F portfolio, value $111,867,661.

    13F-HR 0001694164-25-000003 filed by AustralianSuper Pty Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2024-12-31
    13F 2,668,843 shares
    Change vs previous 13F -604,573 shares

    0.93% of the 13F portfolio, value $197,574,447.

    13F-HR 0001694164-25-000001 filed by AustralianSuper Pty Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-09-30
    13F 3,273,416 shares
    Change vs previous 13F not available

    1.08% of the 13F portfolio, value $216,012,722.

    13F-HR 0001694164-24-000010 filed by AustralianSuper Pty Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).